Rocksolid Light

Welcome to novaBBS (click a section below)

mail  files  register  newsreader  groups  login

Message-ID:  

No, that'd be silly. -- Larry Wall in <199710221710.KAA24242@wall.org>


tech / sci.electronics.design / Re: 12 month mitigation vs suppression strategy Covid19

Re: 12 month mitigation vs suppression strategy Covid19

<6gbgvgh4fgt4mcgiapspru2q4hm9uj1orj@4ax.com>

  copy mid

https://www.novabbs.com/tech/article-flat.php?id=88942&group=sci.electronics.design#88942

  copy link   Newsgroups: sci.electronics.design
Path: i2pn2.org!i2pn.org!eternal-september.org!reader02.eternal-september.org!.POSTED!not-for-mail
From: leg...@nospam.magma.ca (legg)
Newsgroups: sci.electronics.design
Subject: Re: 12 month mitigation vs suppression strategy Covid19
Date: Mon, 31 Jan 2022 13:45:47 -0500
Organization: A noiseless patient Spider
Lines: 278
Message-ID: <6gbgvgh4fgt4mcgiapspru2q4hm9uj1orj@4ax.com>
References: <j7j09g9scnbt36up5iidf1tef0shcsocsk@4ax.com> <ppqibgdqa2kcs6dr4fd064st0rlu6gd9nb@4ax.com> <0b86eg1s60nru5m1i8no5qmv674km2ipl1@4ax.com> <j6gggglco2l0o8vocov4gvai653136lu27@4ax.com> <kh2qig9tl6afa4j9cp32iffsaelvln25k4@4ax.com> <gc9cjg5jlsqu57gc18cj2feq87ujbrpged@4ax.com> <4i0plgps4aqj115kj5l7mvf7hfh678a8at@4ax.com> <pr51oghhnscrbfvp6o92l8orpcsdm1enc9@4ax.com> <4qkhqgp8jme81ss002hi3fg35j5s06oe0a@4ax.com> <kht6tgp3ool8jr80j05m55oeq447e7im7r@4ax.com>
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
Injection-Info: reader02.eternal-september.org; posting-host="98ad756dac17f2ecd995dd4318d44e9a";
logging-data="12046"; mail-complaints-to="abuse@eternal-september.org"; posting-account="U2FsdGVkX1/ECJxohnDhDBun7wktBSN2"
Cancel-Lock: sha1:whCXfTOkxIB6lgkCywiWzS46dOQ=
X-Newsreader: Forte Agent 4.2/32.1118
 by: legg - Mon, 31 Jan 2022 18:45 UTC

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within a population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate, in eaerly 2020.

> Testing for antibodies in India in May/Jun 2021, indicated that
> Covid 19 exposure was present in 67% of test subjects. This
> compared to a 7% figure recorded in the fall of 2020. A daily
> infection rate in excess of 2000ppm is suggested by this change.

> http://tiny.cc/cn8muz

>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>

> Comparison charts, as of Dec 31 are available:

> http://ve3ute.ca/query/211231_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/211231_cases_daily_ppm_report_group.jpg

> http://ve3ute.ca/query/211231_deaths_report_group.jpg
> http://ve3ute.ca/query/211231_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/211231_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/211130_deaths_daily_greater_than_5ppm.jpg

> http://ve3ute.ca/query/211231_vaccine_doses_report_group.jpg
> http://ve3ute.ca/query/211231_vaccine_doses_daily_report_group.jpg
> http://ve3ute.ca/query/211231_vaccinations_completed_report_group.jpg

> Flu Season? Fatality comparison to past events in the U.S.A.
> Updated Dec 31 to include a second year trend or 'season'.

> http://ve3ute.ca/query/flu_season_028b.jpg

> Looks like everyone's going to get it, eventually, vaccinated
> or not - just reduced mortality amongst the vaccinated.

A possible peaking in covid-omicron detections may be indicated.

As of Jan31:
US detections are at 223279ppm.(22.3%)
Detection rate is 1481ppm/day and falling.
Fatalities are 2656ppm at 7.1ppm/day.
FR is 1.3% from a 211753ppm detection recorded 7 days previously.
Case FR short term is currently 0.3%.
US test rate is 5820ppm/day
25.4% of current tests are positive.
Vaccinations at 162% at 1400ppm/day
- with 64% fully vaccinated.

Canada detections at 79695ppm (8.0%) ~ 363 days behind the US.
Detection rate at 460ppm/day and falling.
Fatalities are 886ppm at 4.4ppm/day. ~ 417 days behind the US.
FR is 1.2% from a 75802ppm detection recorded 7 days previously.
Case FR short term is currently 0.6%.
Canada test rate is 2380ppm/day
19.3% of current tests are positive.
Vaccinations at 204% at 6600ppm/day
- with 79% fully vaccinated.

Italy detections at 180783ppm. (18.1%)
Detection rate is 2371ppm/day and falling.
Fatalities are 2421ppm at 6.2ppm/day.
FR is 1.5% from a 162028ppm detection recorded 7 days previously.
Case FR short term is currently 0.2%.
Italy test rate is 16970ppm/day.
14.0% of current tests are positive.
Vaccinations at 212% at 8200ppm/day.
- with 76% fully vaccinated.

Sweden detections at 203782ppm (20.4%)
Detection rate is 4028ppm/day and rising to exceed test capacity.
Fatalities are 1561ppm at 2.5ppm/day.
FR is 0.9% from a 175588ppm detection recorded 7 days previously.
Case FR short term is currently 0.1%.
Sweden test rate is 8400ppm/day.
No test positivity rate is practical.
Vaccinations at 189% at 7600ppm/day
- with 74% fully vaccinated.

UK detections at 242049ppm. (24.2%)
Detection rate is 1282ppm/day and falling.
Fatalities are 2285ppm at 3.9ppm/day.
FR is 1.0% from a 231980ppm detection recorded 7 days previously.
Case FR short term is currently 0.3%.
UK test rate is 19960ppm/day.
6.4% of current tests are positive.
Vaccinations at 202% at 1500ppm/day
- with 71% fully vaccinated.

Brazil detections at 118511ppm. (11.9%)
Detection rate is 672ppm/day and rising to exceed test capacity.
Fatalities are 2931ppm at 2.5ppm/day
FR is 2.6% from an 111833ppm detection recorded 7 days previously.
Case FR short term is currently 0.5% .
Brazil test rate is 330ppm/day.
No test positivity rate is practical.
Vaccinations at 169% at 5600ppm/day
- with 70% fully vaccinated.

Peru detections at 96656ppm. (9.7%)
Detection rate is 1192ppm/day and leveling above test capacity.
Fatalities are 6160ppm at 5.1ppm/day.
FR is 7.1% from a 86759ppm detection recorded 7 days previously.
Case FR short term is currently 0.4% .
Peru test rate is unreported.
No test positivity rate is practical.
Vaccinations at 166% at 2800ppm/day
- with 68% fully vaccinated

Chile detections at 111269ppm (11.1%)
Detection rate is 1282ppm/day and rising.
Fatalities are 2066ppm at 1.3ppm/day.
FR is 2.1% from a 97677ppm detection recorded 14 days previously.
Case FR short term is currently 0.3% .
Chile test rate is 5170ppm/day.
24.8% of current tests are positive.
Vaccinations at 242% at 3000ppm/day
- with 88% fully vaccinated.

Argentina detections at 182766ppm (18.3%)
Detection rate is 1491ppm/day and falling.
Fatalities are 2653ppm at 5.7ppm/day.
FR is 1.6% from a 170870ppm detection recorded 7 days previously.
Case FR short term is currently 0.2% .
Argentina test rate is 2550ppm/day.
No test positivity rate is practical.
Vaccinations at 181% at 7000ppm/day
- with 76% fully vaccinated.

Mexico detections at 37847ppm (3.8%)
Detection rate is 288ppm/day and rising to exceed test capacity.
Fatalities are 2348ppm at 3.0ppm/day.
FR is 6.7% from a 35280ppm detection recorded 7 days previously.
Case FR short term is currently 1.1% .
Mexico test rate is 340ppm/day.
No test positivity rate is practical.
Vaccinations at 127% at 5600ppm/day.
- with 59% fully vaccinated.

South Africa detections at 60022ppm (6.0%)
Detection rate is 53ppm/day and falling.
Fatalities are 1583ppm at 2.0ppm/day.
FR is 2.7% from a 59615ppm detection recorded 7 days previously.
Case FR short term is currently 3.2% .
SA test rate is 540ppm/day.
9.8% of current tests are positive.
Vaccinations at 50% at 1000ppm/day
- with 28% fully vaccinated.(a rounding error?)

Czech detections at 278747ppm (27.9%)
Detection rate is 3178ppm/day and rising.
Fatalities are 3476ppm at 2.0ppm/day.
FR is 1.4% from a 254785ppm detection recorded 7 days previously.
Case FR short term is currently 0.1% .
Czech test rate is 12870ppm/day.
24.7% of current tests are positive.
Vaccinations at 159% at 3000ppm/day
- with 63% fully vaccinated.

India detections at 29641ppm (3.0%)
Detection rate is 180ppm/day and leveling below 200ppm/day.
Fatalities at 355ppm at 0.5ppm/day.
FR is 1.3% from a 28159ppm detection recorded 7 days previously.
Case FR short term is currently 0.2% .
India test rate 1250ppm/day.
14.4% of current tests are positive.
Vaccinations at 119% at 3600ppm/day
- with 50% fully vaccinated.

Israel detections at 304612ppm (30.4%)
Detection rate is 9496ppm/day and rising.
Fatalities at 939ppm at 5.1ppm/day.
FR is 0.4% from a 238143ppm detection recorded 7 days previously.
Case FR short term is currently 0.1% .
Israel test rate is 37470ppm/day.
25.3% of current tests are positive
Vaccinations at 192% at 1100ppm/day.
- with 65% fully vaccinated.

Fatality rate hotspots (>5ppm/day) :

Bosnia - 14.2ppm/day
Croatia - 13.0ppm/day
Macedonia - 11.3ppm/day
Bulgaria - 10.3ppm/day
Greece - 10.2ppm/day
Trinidad and Tobago - 9.5ppm/day
Georgia - 8.8ppm/day
USA - 7.1ppm/day
Hungary - 6.9ppm/day
Italy - 6.2ppm/day
Uruguay - 6.2ppm/day
Serbia - 6.1ppm/day
Guyana - 5.8ppm/day
Argentina - 5.7ppm/day
Lithuania - 5.4ppm/day
Latvia - 5.5ppm/day
Surinam - 5.1ppm/day
Columbiaia - 5.1ppm/day
Peru - 5.1ppm/day
Israel - 5.1ppm/day

> Doses applied in Israel, Chile and other highly vaccinated countries
> appear to be providing 3rd dose booster reinforcement, without
> contributing to completed vaccinations.

> Full vaccination levels are apparently stalled around 60% in the US
> and other regions with signifigant reactionary movements.

> The increased transmissibility of omicron variants have contributed
> to the rise in detections, world-wide, after Nov 2021. So far, no
> increase in mortality is associated with this variant.

> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>

> Reducing detections and fatalities in unvaccinated India/Nepal
> seem to indicate reducing virulence for the delta variant.
> Detection rates in S.Africa had also turned around until the
> recent influences of the omicron variant. So far there is no
> corresponding increase in fatalities.

RL

SubjectRepliesAuthor
o 12 month mitigation vs suppression strategy Covid19

By: legg on Mon, 3 May 2021

130legg
server_pubkey.txt

rocksolid light 0.9.81
clearnet tor